RESUMO
Presentamos el caso de un paciente de 20 años con diagnóstico previo de parálisis cerebral infantil y que a la exploración física presentaba un trastorno del desarrollo. Se le realizó una tomografía computarizada (TC) craneal y una resonancia magnética (RM) craneal convencional con lo que se diagnosticó de síndrome de Joubert. Se completó el estudio con un tensor de difusión y una tractografía. En este artículo se revisan los hallazgos en las técnicas de imagen en este síndrome y la bibliografía (AU)
We present the case of a 20-year-old man previously diagnosed with cerebral palsy in whom a developmental disorder was detected at physical examination. After cranial CT and conventional cranial MRI, we diagnosed Joubert syndrome. We completed the study with diffusion tensor imaging and tractography. This article reviews the imaging findings for Joubert syndrome and the relevant literature (AU)
Assuntos
Humanos , Masculino , Adulto , /métodos , Paralisia Cerebral , Doenças Cerebelares/congênito , Doenças Cerebelares , Cerebelo/anormalidades , Cerebelo , /instrumentação , /tendências , /métodosRESUMO
We present the case of a 20-year-old man previously diagnosed with cerebral palsy in whom a developmental disorder was detected at physical examination. After cranial CT and conventional cranial MRI, we diagnosed Joubert syndrome. We completed the study with diffusion tensor imaging and tractography. This article reviews the imaging findings for Joubert syndrome and the relevant literature.
Assuntos
Doenças Cerebelares/diagnóstico , Imagem de Tensor de Difusão , Anormalidades do Olho/diagnóstico , Doenças Renais Císticas/diagnóstico , Imageamento por Ressonância Magnética , Anormalidades Múltiplas , Cerebelo/anormalidades , Humanos , Masculino , Retina/anormalidades , Adulto JovemRESUMO
BACKGROUND AND METHODS: The available data on the utility of low-molecular-weight heparins (LMWH) in the secondary prophylaxis of deep vein thrombosis (DVT) are limited. We compared two cohorts of patients diagnosed of DVT. One group followed treatment with LMWH and the other group did with oral anticoagulants (acenocoumarol). Safety was evaluated by the rate of major hemorrhage and 2.5-years period fracture rate, and efficacy was evaluated as the rate of early recurrence and one-year recurrence rate. RESULTS: Of 65 patients treated with LMWH, the hemorrhagic rate was 1.5% (95% CI 0.08-9.40), fracture rate was 7.7% (95% CI 2.87-17.75), early recurrence was 1.5% (95% CI 0.08-9.40) and one-year recurrence was 3% (95% CI 53-11.64). In 118 patients treated with oral anticoagulants the hemorrhagic rate was 3.4% (95% CI 1.09-8.97), odds ratio 0.33, the fracture rate was 11% (95% CI 16.23-18.44), odds ratio 0.66, the early recurrence rate was 5% (95% CI 2.08-11.20), odds ratio 0.60 and one-year recurrence was 3.4% (95%CI 1.09-8.97), odds ratio 0.33. CONCLUSIONS: Secondary prophylaxis of DVT with LMWH is as safe and effective as classical treatment with oral anticoagulants. In this study the 2.5-year period fracture rate was similar in both groups of treatment.
